Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 3
Submit an article Journal homepage
110
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Neurolymphomatosis as a relapse of primary cerebral nervous system lymphoma

Loïc Le GuennecService de Neurologie 2-Mazarin, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Correspondence[email protected]
,
Thierry MaisonobeService de Neurophysiologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France;
,
Sylvain ChoquetService D’Hématologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France;
,
Audrey MasseinService de Radiologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France;
,
Arièle Azoulay-CaylaService de Neurophysiologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France;
,
Nicolas VillainService de Neurologie 2-Mazarin, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France;
,
Frederique ArchambaudService Biophysique Et Médecine Nucléaire, AP-HP, Hôpital Bicêtre, France;
,
Khe Hoang-XuanService de Neurologie 2-Mazarin, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ;Inserm, U 1127, Paris, France; ;CNRS, UMR 7225, Paris, France; ;Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; ;Institut Du Cerveau Et de La Moelle Épinière, ICM, Paris, France
&
Ahmed IdbaihService de Neurologie 2-Mazarin, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; ;Inserm, U 1127, Paris, France; ;CNRS, UMR 7225, Paris, France; ;Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France; ;Institut Du Cerveau Et de La Moelle Épinière, ICM, Paris, France
 show all
Pages 729-731 | Received 08 Mar 2016, Accepted 28 Jun 2016, Published online: 09 Aug 2016

References

  • Jahnke K, Thiel E, Martus P, et al. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol. 2006;80:159–165.
  • Provencher S, Ferlay C, Alaoui-Slimani K, et al. Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series. Hematol Oncol. 2011;29:10–16.
  • Kim JE, Yoon DH, Kim S, et al. Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma. Korean J Hematol. 2012;47:60–66.
  • Baehring JM, Damek D, Martin EC, et al. Neurolymphomatosis. Neuro-oncology. 2003;5:104–115.
  • Borit A, Altrocchi PH. Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol. 1971;24:40–49.
  • Trelles JO, Trelles L. [Human peripheral neurolymphomatosis]. Rev Neurol (Paris). 1983;139:703–714.
  • Vallat JM, De Mascarel HA, Bordessoule D, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies–13 cases. Brain. 1995;118:1233–1245.
  • Ferreri AJ, Cwynarski K, Pulczynski E, et al. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016;3:e217–e227.
  • Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood. 2010;115:5005–5011.
  • Batchelor T, Carson K, O'Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol. 2003;21:1044–1049.
  • Pels H, Schulz H, Schlegel U, et al. Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literature. Onkologie. 2003;26:351–354.
  • Rubenstein JL, Combs D, Rosenberg J, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2003;101:466–468.
  • Gray JR, Wallner KE. Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia. Int J Radiat Oncol Biol Phys. 1990;19:439–444.
  • Shenkier TN. Unusual variants of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005;19:651–664.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.